Literature DB >> 6486760

Growth of group IV mycobacteria on medium containing various saturated and unsaturated fatty acids.

H Saito, H Tomioka, T Yoneyama.   

Abstract

Seventy-one strains of 15 species of rapidly growing mycobacteria were studied for their susceptibilities to fatty acids with 2 to 20 carbons by the agar dilution method at pH 7.0. Most mycobacteria other than potential pathogens (Mycobacterium fortuitum and Mycobacterium chelonei) were resistant to saturated fatty acids, except for lauric acid (C12:0) (MIC, 6.25 to 25 micrograms/ml) and capric acid (C10:0) (MIC, 50 to 100 micrograms#ml). M. fortuitum and M. chelonei were substantially insusceptible to these fatty acids. Unsaturated fatty acids with 16 to 20 carbons, except for C20:5, were highly toxic to group IV mycobacteria other than M. fortuitum, M. chelonei, Mycobacterium smegmatis, and Mycobacterium phlei, these being highly resistant to all the unsaturated acids, except for C16:1, C18:3, and C20:5. Introduction of double bonds to C16 to C20 fatty acids caused a marked increase in their activities that depended on the increase in the number of double bonds, at least up to three or four. M. fortuitum and M. chelonei were more resistant to the unsaturated fatty acids (particularly to C20:3 and C20:4) than the other group IV mycobacteria.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6486760      PMCID: PMC284112          DOI: 10.1128/AAC.26.2.164

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  A co-operative numerical analysis of rapidly growing mycobacteria.

Authors:  G P Kubica; I Baess; R E Gordon; P A Jenkins; J B Kwapinski; C McDurmont; S R Pattyn; H Saito; V Silcox; J L Stanford; K Takeya; M Tsukamura
Journal:  J Gen Microbiol       Date:  1972-11

2.  Mycobacterium rhodesiae sp. nov. A new species of rapid-growing scotochromogenic mycobacteria.

Authors:  M Tsukamura; S Mizuno; N F Gane; A Mills; L King
Journal:  Jpn J Microbiol       Date:  1971-09

3.  Mycobacterium chitae: a new species.

Authors:  M Tsukamura
Journal:  Jpn J Microbiol       Date:  1967-03

4.  The lethal effect of long-chain fatty acids on mycobacteria.

Authors:  E Kondo; K Kanai
Journal:  Jpn J Med Sci Biol       Date:  1972-02

5.  Antibacterial activity of long chain fatty acids and the reversal with calcium, magnesium, ergocalciferol and cholesterol.

Authors:  H Galbraith; T B Miller; A M Paton; J K Thompson
Journal:  J Appl Bacteriol       Date:  1971-12

6.  [Mycobacterium aurum; a new species].

Authors:  M Tsukamura; S Tsukamura
Journal:  Igaku To Seibutsugaku       Date:  1966-05-10

7.  [Mycobacterium parafortuitum (a new species)].

Authors:  M Tsukamura; H Toyama; S Mizuno
Journal:  Igaku To Seibutsugaku       Date:  1966-04-10

8.  A study of some fast-growing scotochromogenic mycobacteria including species descriptions of Mycobacterium gilvum (new species) and Mycobacterium duv alii (new species).

Authors:  J L Stanford; W J Gunthorpe
Journal:  Br J Exp Pathol       Date:  1971-12

9.  Effects of fatty acids on growth and envelope proteins of Bacillus subtilis.

Authors:  C W Sheu; E Freese
Journal:  J Bacteriol       Date:  1972-08       Impact factor: 3.490

10.  Growth inhibition among strains of Neisseria gonorrhoeae due to production of inhibitory free fatty acids and lysophosphatidylethanolamine: absence of bacteriocins.

Authors:  D L Walstad; R C Reitz; P F Sparling
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

View more
  12 in total

Review 1.  Targeting InhA, the FASII enoyl-ACP reductase: SAR studies on novel inhibitor scaffolds.

Authors:  Pan Pan; Peter J Tonge
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

Review 2.  The emerging role of peptides and lipids as antimicrobial epidermal barriers and modulators of local inflammation.

Authors:  N K Brogden; L Mehalick; C L Fischer; P W Wertz; K A Brogden
Journal:  Skin Pharmacol Physiol       Date:  2012-04-26       Impact factor: 3.479

3.  Effect of ofloxacin combined with Lactobacillus casei against Mycobacterium fortuitum infection induced in mice.

Authors:  H Tomioka; K Sato; H Saito
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

4.  Susceptibilities of transparent, opaque, and rough colonial variants of Mycobacterium avium complex to various fatty acids.

Authors:  H Saito; H Tomioka
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

5.  2-methoxylated fatty acids in marine sponges: defense mechanism against mycobacteria?

Authors:  Néstor M Carballeira; Heidyleen Cruz; Cecil D Kwong; Baojie Wan; Scott Franzblau
Journal:  Lipids       Date:  2004-07       Impact factor: 1.880

6.  Ancestral antibiotic resistance in Mycobacterium tuberculosis.

Authors:  Rowan P Morris; Liem Nguyen; John Gatfield; Kevin Visconti; Kien Nguyen; Dirk Schnappinger; Sabine Ehrt; Yang Liu; Leonid Heifets; Jean Pieters; Gary Schoolnik; Charles J Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-15       Impact factor: 11.205

Review 7.  Conventional and unconventional antimicrobials from fish, marine invertebrates and micro-algae.

Authors:  Valerie J Smith; Andrew P Desbois; Elisabeth A Dyrynda
Journal:  Mar Drugs       Date:  2010-04-14       Impact factor: 5.118

8.  Synthesis and biological activity of alkynoic acids derivatives against mycobacteria.

Authors:  Catherine Vilchèze; Lawrence W Leung; Robert Bittman; William R Jacobs
Journal:  Chem Phys Lipids       Date:  2015-08-06       Impact factor: 3.329

Review 9.  New advances in fatty acids as antimalarial, antimycobacterial and antifungal agents.

Authors:  N M Carballeira
Journal:  Prog Lipid Res       Date:  2007-11-01       Impact factor: 16.195

10.  Oral mucosal lipids are antibacterial against Porphyromonas gingivalis, induce ultrastructural damage, and alter bacterial lipid and protein compositions.

Authors:  Carol L Fischer; Katherine S Walters; David R Drake; Deborah V Dawson; Derek R Blanchette; Kim A Brogden; Philip W Wertz
Journal:  Int J Oral Sci       Date:  2013-07-19       Impact factor: 6.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.